Andrew Guggenhime
Director; PRESIDENT AND CFO · 7 filings · Latest: Aug 3, 2026
Caribou Biosciences, Inc.
Vaxcyte, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
PCVX | Andrew Guggenhime | PRESIDENT AND CFO | Aug 3, 2026 | Sale | $53.89 | 10,000 | $538.9K | 105,176 | |
PCVX | Andrew Guggenhime | PRESIDENT AND CFO | Aug 3, 2026 | Option Exercise | $5.35 | 10,000 | $53.5K | 115,176 | |
PCVX | GUGGENHIME ANDREW | — | Aug 3, 2026 | Proposed Sale | $53.99 | 10,000 | $539.9K | — | |
PCVX | Andrew Guggenhime | PRESIDENT AND CFO | Jul 6, 2026 | Sale | $57.28 | 10,000 | $572.8K | 104,395 | |
PCVX | Andrew Guggenhime | PRESIDENT AND CFO | Jul 6, 2026 | Option Exercise | $5.35 | 10,000 | $53.5K | 114,395 | |
PCVX | GUGGENHIME ANDREW | — | Jul 6, 2026 | Proposed Sale | $57.76 | 10,000 | $577.6K | — | |
PCVX | Andrew Guggenhime | PRESIDENT AND CFO | Jun 18, 2026 | Sale | $53.00 | 10,000 | $530.0K | 104,395 | |
PCVX | Andrew Guggenhime | PRESIDENT AND CFO | Jun 18, 2026 | Option Exercise | $5.35 | 10,000 | $53.5K | 114,395 | |
PCVX | GUGGENHIME ANDREW | — | Jun 18, 2026 | Proposed Sale | $53.00 | 10,000 | $530.0K | — | |
PCVX | GUGGENHIME ANDREW | — | Feb 18, 2025 | Proposed Sale | $102.08 | 8,000 | $816.6K | — | |
PCVX | GUGGENHIME ANDREW | — | Jan 21, 2025 | Proposed Sale | $86.06 | 8,000 | $688.5K | — | |
PCVX | GUGGENHIME ANDREW | — | Dec 18, 2024 | Proposed Sale | $89.83 | 8,000 | $718.6K | — | |
PCVX | GUGGENHIME ANDREW | — | Nov 18, 2024 | Proposed Sale | $86.50 | 8,000 | $692.0K | — | |
PCVX | GUGGENHIME ANDREW | — | Oct 18, 2024 | Proposed Sale | $115.88 | 42,000 | $4.9M | — | |
PCVX | GUGGENHIME ANDREW | — | Sep 18, 2024 | Proposed Sale | $116.75 | 8,000 | $934.0K | — |